Redhill Biopharma
RDHL
17 hedge funds and large institutions have $514K invested in Redhill Biopharma in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
905% more capital invested
Capital invested by funds: $51.2K → $514K (+$463K)
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
21% more funds holding
Funds holding: 14 → 17 (+3)
14.29% more ownership
Funds ownership: 0.71% → 15% (+14%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YAG
Yorkville Advisors Global
Mountainside,
New Jersey
|
+$520K |
| 2 |
GS
Gagnon Securities
New York
|
+$91.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$20.8K |
| 4 |
GI
GAMMA Investing
Foster City,
California
|
+$6.31K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$1.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SS
SBI Securities
Tokyo,
Japan
|
-$71 |
| 2 |
RIL
Rothschild Investment LLC
Chicago,
Illinois
|
-$37 |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$9 |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7 |
RDHL Hedge Fund Activity: Q4 2025 in Review
17 of the 8,256 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q4 2025, worth a combined $514K — up 905% from $51.2K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new RDHL positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Yorkville Advisors Global, opening a new position worth an estimated $520K. The largest seller was SBI Securities, cutting an estimated $71.
- 17 institutional investors held Redhill Biopharma (RDHL) as of Q4 2025, up from 14 in Q3 2025.
- Funds reported $514K of Redhill Biopharma stock for Q4 2025, up 905% quarter-over-quarter.
- 4 funds opened new Redhill Biopharma positions in Q4 2025 and 1 closed out, a net change of +3 holders.
- The largest Redhill Biopharma buyer in Q4 2025 was Yorkville Advisors Global, an estimated $520K added.
- The largest Redhill Biopharma seller in Q4 2025 was SBI Securities, an estimated $71 sold.
Based on aggregated 13F filings for Q4 2025.